Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
198.4000
-4.88
(
-2.40
%)
NSE
May 12, 2026
15:31 PM
26.71% Fall from 52W High
Volume:
2.0M
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
04 Oct 2023
198.40
-2.40%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 149
Target
Ventura
Consolidating on the back of the Teva acquisition
Number of FII/FPI investors increased from 137 to 145 in Mar 2026 qtr.
More from Marksans Pharma Ltd.
Recommended
Five stocks to buy from analysts this week - May 12, 2026
The Baseline |
12 May 2026, 05:09PM
Market closes lower, weighed down by crude surge and rupee's record low
Trendlyne Marketwatch |
12 May 2026, 04:01PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017